84
Participants
Start Date
May 25, 2004
Primary Completion Date
July 6, 2007
Study Completion Date
July 6, 2007
Placebo
placebo injectable subcutaneously daily into thigh or abdomen
Teduglutide 0.05 mg/kg/d
Teduglutide 0.05 mg/kg/d daily injectable subcutaneously into the thigh or abdomen
Teduglutide 0.1 mg/kg/d
Teduglutide 0.1 /g/kg/d daily injection subcutaneously into thigh or abdomen
l'Hôpital Erasme, Brussels
Rigshospitalet, University of Copenhagen, Copenhagen
Mount Sinai School of Medicine, New York
Charité University Hospital, Berlin
Albany Medical Center, Albany
Charité-Universitätsmedizin Berlin, Berlin
University of Rochester Medical Center, Rochester
University of Pittsburgh Medical Center, Pittsburgh
University of Pennsylvania - Penn Nursing, Philadelphia
Georgetown University, Washington D.C.
Medical University of South Carolina, Charleston
Emory University Hospital, Atlanta
The Cleveland Clinic Foundation, Cleveland
Hôpital Claude-Huriez, Lille
Universitätsklinikum Frankfurt, Frankfurt
Northwestern Center for Clinical Research, Chicago
University of Kansas Medical Center, Kansas City
University of Nebraska Medical Center, Omaha
Hôpital de la Croix-Rousse, Lyon
Hôpital Edouard Herriot, Lyon
Mayo Clinic Scottsdale, Scottsdale
Hôpital Beaujon, Paris
Rhode Island Hospital, Providence
Royal Alexandra Hospital, Edmonton
St. Paul's Hospital, Vancouver
St. Michael's Hospital, Toronto
Toronto General Hospital, Toronto
Academic Medical Center, Amsterdam
Pracownia Żywienia Klinicznego, Olsztyn
Samodzielny Publiczny Szpital Kliniczny-Im.prof W.Orłowskiego CMKP, Warsaw
Hope Hospital, Salford
St. Mark's Hospital, Harrow
Lead Sponsor
Shire
INDUSTRY